106 related articles for article (PubMed ID: 11783506)
1. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
[No Abstract] [Full Text] [Related]
2. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
Virchis A; Mehta A
Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
[No Abstract] [Full Text] [Related]
3. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
4. Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line.
Wall NR; Beck FW; Al-Katib AM; Mohammad RM
J Drug Target; 2001; 9(5):329-39. PubMed ID: 11770703
[TBL] [Abstract][Full Text] [Related]
5. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
6. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
7. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
[No Abstract] [Full Text] [Related]
8. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
[No Abstract] [Full Text] [Related]
10. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Juliusson G; Elmhorn-Rosenborg A; Liliemark J
N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
[TBL] [Abstract][Full Text] [Related]
12. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
Carrera CJ; Piro LD; Saven A; Beutler E; Terai C; Carson DA
Adv Exp Med Biol; 1991; 309A():15-8. PubMed ID: 1686349
[No Abstract] [Full Text] [Related]
13. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
[TBL] [Abstract][Full Text] [Related]
14. 2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Gruber J; Geisen F; Sgonc R; Egle A; Villunger A; Boeck G; Konwalinka G; Greil R
Stem Cells; 1996 May; 14(3):351-62. PubMed ID: 8724701
[TBL] [Abstract][Full Text] [Related]
15. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
[No Abstract] [Full Text] [Related]
16. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
[No Abstract] [Full Text] [Related]
17. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Piro LD
Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
[No Abstract] [Full Text] [Related]
18. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
[TBL] [Abstract][Full Text] [Related]
19. [Immunological markers of disease activity in the course of 2-CDA treatment of multiple sclerosis].
Michałowska-Wender G; Tokarz-Kupczyk E; Losy J; Sniatała-Kamasa M; Wender M
Neurol Neurochir Pol; 1999; 33(4):749-56. PubMed ID: 10612090
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]